Select All | None | words selected.

Top 50 Keywords:
molecule
model
fatty
liver
chemical
compound
chemistry
atomic
atoms
structure
biochemistry
3d
acid
molecular
nafld
omega-3
oil
fish
epa
eicosapentaenoic
science
depression
computer
nash
algae
3d rendering
cod
molecular structure
composition
eicosanoid
herring
polyunsaturated
unsaturated
timnodonic
bond
sardine
salmon
pufa
prostaglandin
precursor
disease
crystal
skeletal
pharmacology
structural
chemical formula
chemical compound
chain
built structure
receptor

Other Keywords:
medicine
metabolism
research
dyslipidemia
kiwifruit
elafibranor
antioxidant
breast
cofactor
dehydrogenase
enzyme
glucose
kiwi
milk
formula
neuroprotection
neuroprotective
nonalcoholic
pqq
pyrroloquinoline
quinone
quinoprotein
redox
scientific
atom
vitamin
proliferator-activated
pharmaceutical
drug
fibrosis
insulin
diabetes
medicinal
treatment
ppar
steatohepatitis
pharmacy
therapy
peroxisome
medicinal chemistry
isolated
carbon
drug development
biology
medical
mechanism of action
fatty liver disease
anti-inflammatory
pharmaceutical research
cardiometabolic
pharma
anti-fibrotic
3d illustration
non-alcoholic
oxygen

ketonuria
ketosis
anticonvulsant
amide functional group
depamide
antiepileptic drug
bipolar disorder therapy
c8h17no
carboxamide
central nervous system agent
depression adjunct therapy
ketonemia
acc inhibitor agent
ketone
brain
side effects
therapeutic agent
toxicology
acetoacetic
acetyl-coa
acidic
body
carbohydrate
ketogenic
citric
diabetic
epilepsy treatment
diet
energy
hydrogen
ketoacidosis
ketogenesis
dipropylacetamide
teratogenic risk
european market availability
long-chain
black
coding
fabp1
fabpl
hydrophobic
l-fabp
lcfa
obesity
binding
product
protein
realistic
render
transport
small molecule drug
steatohepatitis therapy
tvb-2640
bioinformatics
altered

fatty amide
rapid metabolism to valproic acid
limited water solubility
liver microsomal epoxide hydrolase inhibitor
manic episode adjunct therapy
melting point 125°c
mood stabilizer
potential drug interactions
psychomotor agitation adjunct
safety
ppar agonists
valproic acid derivative
valpromide
white crystalline powder
c22h24o4s
cardiometabolic diseases
experimental medication
gft505
insulin resistance
sefa-6179
medium chain fatty acid analogue
receptor binding
biopharmaceutical
investigational compound
hepatic fibrosis
fatty acid synthase
fasn inhibitor
enzyme inhibitor
denifanstat
clinical trial drug
c27h29n5o
biochemistry research
lipogenesis inhibitor
anti-diabetic
anti-obesity
anti-proliferative
c19h27fo
cell signaling
clinical trial
cushing's syndrome
development
dhea analog
lipid metabolism
liver disease
fluorine
metabolic disorder treatment agent
c28h31n3o8s
enzyme inhibition mechanism
fatty acid synthesis inhibitor
firsocostat
fluorinated compound
hepatic steatosis therapy
heterocyclic scaffold
lipid metabolism modulator
liver disease agent

molecular conformation
mash treatment
nash therapy candidate
pharmacological activity
signal transduction modulation
therapeutic target interaction
sagimet biosciences
palmitate synthesis
oral medication
molecular biology
metabolic disease
fluasterone
g6pd inhibitor
pharmacokinetics
efficacy
nutritional supplement
omega-3 fatty acid
antifibrotic agent
bioavailability
c13h18o3
clinical trials
dosage
drug design
enzyme inhibition
medication
formulation
intestinal failure-associated liver disease
investigational drug
liver disease treatment
acetyl coa carboxylase inhibitor drug
molecular interactions
molecular modeling
orziloben
pharmacodynamics
nutrient
lipid
he-2500
therapeutic
hyperglycemia
asc-40
nonalcoholic fatty liver disease
orphan drug
preclinical
anticancer activity
steroid
steroidogenesis
synthetic
biological
laboratory
c20h30o2
cod liver oil
concentration
eicosapentaenoic acid
essential
fatty acid

fish oil
health care
icosapentaenoic acid
administration